Rockville, MD — August 14, 2026 — The global Biotech Ingredients Market is valued at USD 78.3 billion in 2025 and is projected to reach USD 156 billion by 2035, expanding at a 7.2% CAGR from 2025 to 2035, according to Fact.MR.

The market is moving toward biotechnology-based production as pharmaceutical, cosmetic, food, and nutraceutical companies seek more sustainable and functional ingredients. Fermentation, synthetic biology, cell culture, and microbial technologies are helping manufacturers develop high-purity ingredients with more controlled performance. Demand for clean-label and natural products is also encouraging producers to replace some traditional chemical processes with bio-based manufacturing.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=10735 

Sustainability and Innovation Reshape Ingredient Supply

Fact.MR identifies sustainability, regulation, and innovation as important forces shaping the market. About 81% of stakeholders surveyed by Fact.MR focused on developing ingredients with low environmental impact, while 74% highlighted the need to meet changing global standards. In addition, 69% cited speed of innovation as an important consideration.

Fact.MR also reports that 65% of surveyed stakeholders use synthetic biology and AI in fermentation processes, while 58% implement blockchain solutions for ingredient traceability. Further, 77% intend to increase investments in biomanufacturing and green-chemistry innovation. These figures are from Fact.MR's stakeholder survey rather than third-party organizations.

Editorial note: The currently published Fact.MR page does not provide 2–3 dated third-party numerical statistics from named external sources. Therefore, none have been added to avoid introducing unsupported figures.

Key Numbers

Source: Fact.MR.

Segment Breakdown

Active Cosmetic Ingredients: Active cosmetic ingredients led the Product segment in 2025 with a 47.7% share, according to Fact.MR. Demand is supported by applications in anti-aging, moisturizing, brightening, and soothing products.

Flavors: Flavors accounted for 28.2% of the market in 2025. Biotechnology-derived flavorings are gaining attention as food and beverage manufacturers seek natural, clean-label, and sustainable flavor solutions.

Yeast: Yeast represented 37.5% of flavor-ingredient sources in 2025. Yeast-based ingredients are used in beverages, snacks, sauces, and plant-based products.

Filamentous Fungi: This source accounted for 36.5% in 2025. Its applications include savory and sweet flavor profiles, including plant-based products.

Country Growth Outlook

Source: Fact.MR.

China is projected to record the fastest growth among the countries listed, at 9.1% CAGR. Rising healthcare spending, biotechnology investment, personalized medicine, and demand for high-performance cosmetics support its outlook. The U.S. follows at 8.2% CAGR, supported by pharmaceutical innovation, biotechnology research, and sustainable ingredient investment.

South Korea is projected to grow at 7.9%, while Germany is forecast at 7.6%. The U.K. is expected to expand at 7.4%, and Japan at 7.2%.

Competitive Landscape

The competitive landscape includes Givaudan SA, International Flavors & Fragrances Inc. (IFF), Evonik Industries AG, BASF SE, Amyris Inc., Lonza Group AG, Merck KGaA, Sanofi SA, AbbVie Inc., and Advanced Biotech.

Fact.MR estimates Givaudan SA at 18–22%, IFF at 14–18%, Evonik Industries AG at 12–15%, BASF SE at 10–13%, and Amyris Inc. at 7–10% of the market. Other players collectively account for an estimated 22–29%.

Givaudan and IFF are positioned strongly through bio-sourced ingredients, fermentation capabilities, and strategic portfolio expansion. Evonik focuses on pharmaceutical-grade biotech actives, while BASF combines biotechnology with fermentation and R&D capabilities. Lonza and Merck are important participants in pharmaceutical and biotech applications.

Analyst Commentary

The current Fact.MR page identifies S.N. Jha as the report author, but it does not publish a direct analyst quotation. Therefore, no quotation has been created or attributed to the analyst.

Frequently Asked Questions

How big is the biotech ingredients market globally?
The market is estimated at USD 78.3 billion in 2025, according to Fact.MR.

What is the biotech ingredients market forecast for 2035?
Fact.MR projects the market to reach USD 156 billion by 2035.

What is the CAGR of the biotech ingredients market?
The market is forecast to grow at a 7.2% CAGR from 2025 to 2035.

Which country is expected to grow fastest?
China is projected to record the highest listed country CAGR at 9.1%.

Who are the major biotech ingredients companies?
Key companies include Givaudan, IFF, Evonik, BASF, Amyris, Lonza, Merck, Sanofi, AbbVie, and Advanced Biotech.

Top Trending Reports:

https://www.openpr.com/news/4499084/biodegradable-cut-flower-packaging-market-from-regulatory 

https://www.openpr.com/news/4499095/pharma-packaging-enters-the-zero-defect-era-checkweighers 

https://www.openpr.com/news/4499102/anti-sway-overhead-cranes-for-steel-plant-logistics-market 

https://www.openpr.com/news/4499122/solvent-dyes-market-niche-chemistry-strategic-role 

About Fact.MR

Fact.MR is a market research and consulting firm providing market intelligence, forecasts, competitive analysis, and strategic insights across global industries. Its research supports manufacturers, investors, procurement teams, and business leaders in evaluating market opportunities and making informed decisions.